Best hospitals for organ transplant: An evidence-based comparison guide
Choosing among the best hospitals for organ transplant requires more than relying on reputation or total procedure counts. The most relevant comparison is usually between organ-specific programs, using outcomes, waitlist experience, transplant volume, clinical capabilities, and the patient’s medical profile. The Scientific Registry of Transplant Recipients, or SRTR, provides a central starting point for this analysis. 1
Why there is no universal best hospital
No hospital is objectively best for every transplant candidate. A suitable center may differ according to whether the patient needs a kidney, liver, heart, lung, pancreas, intestine, or a combined transplant, as well as whether the case involves pediatric care, living donation, multiorgan disease, or unusually complex surgery. Location, insurance participation, caregiver support, and the ability to attend repeated follow-up visits also influence practical suitability.
Hospital reputation can provide context, but it should not replace organ-specific evidence. Mayo Clinic, Cleveland Clinic, UCSF Health, UCLA Health, Penn Medicine, NYU Langone Health, UPMC, and Barnes-Jewish are described in the supplied research as major academic or multi-organ transplant providers. Their capabilities are broad, but a patient still needs to evaluate the specific program responsible for the required organ and diagnosis. 2
How SRTR data supports comparisons
SRTR offers a patient-facing system for finding and comparing adult and pediatric transplant programs by organ, location, and medical profile. Available categories include kidney, liver, liver-kidney, heart, lung, pancreas, intestine, kidney-pancreas, heart-lung, and heart-kidney transplantation. Reports address measures such as post-transplant patient and graft survival, mortality while waiting, and time spent on the waiting list. 1
These statistics require careful interpretation. A survival estimate describes historical cohorts and may be risk-adjusted, while a volume figure records activity rather than quality. Results can also vary by organ, transplant type, patient severity, and reporting period. The supplied data specifically cautions that aggregated volume and waitlist counts are inventory signals, not recommendations to choose or avoid a center. 8
Documented multi-organ transplant leaders
Mayo Clinic describes itself as the largest integrated transplant provider in the United States, with adult and pediatric services involving heart, liver, kidney, pancreas, lung, hand, face, and blood and bone marrow transplantation. Its transplant history began with a first clinical transplant in 1963, and the center links its development to continuing transplant research. 3 Penn Transplant Institute reports more than six decades of experience and more than 15,000 solid-organ transplant procedures, with active heart, lung, liver, kidney, pancreas, islet, uterus, and hand programs.
Other major systems provide different combinations of services. IU Health offers adult and pediatric transplantation through Methodist Hospital, University Hospital, and Riley Hospital for Children, with transplant-specialized doctors, surgeons, pharmacists, nurse coordinators, social workers, and dietitians. UCSF, UCLA, Cleveland Clinic, NYU Langone, UPMC, and Barnes-Jewish are also identified in the research as providers with broad organ-transplant or multidisciplinary programs. 7
What procedure volume can and cannot show
Volume can indicate that a team regularly manages technically demanding procedures and postoperative complications, but it is not a standalone quality grade. Vanderbilt Transplant Center reported 960 solid-organ transplants in 2025, described as the highest annual total by one U.S. center according to data attributed to the United Network for Organ Sharing. The same report cited 210 adult and pediatric heart transplants and 149 adult lung transplants during that year. 4
Mayo Clinic’s Arizona Transplant Center reported 917 solid-organ transplants in 2025 and stated that it had performed more adult solid-organ transplants than any other U.S. center during each of the preceding five years. These figures cover heart, lung, kidney, pancreas, and liver procedures, but high volume does not prove that the program is the best match for an individual patient. 5
Organ-specific performance matters most
Program comparisons should focus on the organ involved and the outcomes most relevant to that procedure. UF Health reported that its adult kidney program ranked first nationally for one-year graft survival in the latest SRTR results supplied, while its adult liver program ranked among the country’s top three. Its lung program was reported to meet or exceed national benchmarks in short- and long-term survival, waitlist survival, and timely access. 6
Penn Medicine reports that its outcomes consistently meet or exceed the national average across all organ transplants and identifies its liver program as among the top 10 nationally, while describing its heart program as specializing in challenging cases. Such institutional statements are useful for identifying capabilities, but SRTR program-specific reports remain more appropriate for comparing risk-adjusted outcomes, waiting-list mortality, graft survival, and patient survival across centers.
Eligibility, oversight, and long-term realities
Federal certification requirements apply to U.S. transplant hospitals serving Medicare and Medicaid patients, but certification alone does not establish that one hospital is superior. Eligibility decisions depend on medical evaluation and may include assessment of disease severity, surgical risk, support systems, and the ability to follow a demanding treatment plan. Living-donor programs may add separate education, screening, and suitability requirements. 10
Transplantation also involves continuing maintenance rather than a single operation. Patients should ask programs about organ-specific survival, annual volume, waitlist outcomes, living-donor options, rejection and readmission practices, financial-coordinator support, medication management, and follow-up arrangements. Geographic distance can create burdens because transplant care requires recurring monitoring and coordination with specialists, while insurance networks and lodging arrangements may affect access and continuity.
A practical comparison framework
A structured review can reduce the risk of choosing a center based only on advertising, rankings, or a single headline statistic. The following questions organize the information that should be requested from each program and checked against the relevant SRTR report:
- Does the center perform the required organ or combined transplant for the patient’s medical profile?
- How do patient survival, graft survival, waitlist mortality, and waiting time compare with national and regional benchmarks?
- What are the program’s recent transplant volumes and living-donor capabilities?
- How are complications, rejection, readmissions, rehabilitation, and lifelong follow-up managed?
- Can the patient’s insurance, caregiver network, travel needs, and financial-support requirements be accommodated?
The strongest decision is therefore evidence-based and individualized. SRTR and OPTN data can establish the comparison framework, while consultations with transplant clinicians must determine whether the published results apply to the patient’s diagnosis, urgency, and risk profile. 1
Sources
- Scientific Registry of Transplant Recipients
- Penn Transplant Institute, Penn Medicine
- Mayo Clinic Transplant Center
- Vanderbilt Transplant Center, Vanderbilt Health News
- Mayo Clinic News Network, Arizona Transplant Center
- UF Health Department of Surgery
- IU Health Transplant Services
- PlainTransplant, University of Pittsburgh Medical Center profile
- Centers for Medicare and Medicaid Services
- Organ Procurement and Transplantation Network and National Institute of Diabetes and Digestive and Kidney Diseases
Authored by 24Trendz team